June 2018: We are proud to announce that to this date the actrevo team successfully guided 2 Korean companies through their first
EU GMP inspection. We will continue to provide our expertise and experience and support our partners to access the international human and veterinary healthcare market.
February 14, 2017: actrevo is going to participate at DCAT Week 2017 in New York (March 20-23); https://www.dcat.org/DCATWeek.htm
January 1st, 2017: Establishment of own pharmaceutical development laboratory in Hamburg
July 13, 2016: actrevo is going to participate at CPhI worldwide in Barcelona (October 04-06); http://www.cphi.com
May 05th, 2016: 1st birthday actrevo GmbH
April 22, 2016: actrevo was registered as pharmaceutical entrepreneur (pharmazeutischer Unternehmer)
March 10, 2016: the official wholesale license certification (Großhandelserlaubnis) was issued to actrevo
February 19, 2016: actrevo will participate at euroPLX 60 in Barcelona (March 07 and 08); www.europlx.com
November 12, 2015: Participation at Medica, Düsseldorf in November 2015; www.medica.de
October, 29, 2015: actrevo became member of Gesundheitsmetropole e.V.; www.gwhh.de
October 5, 2015: actrevo became member of Life Science Nord; http://www.lifesciencenord.de
September 11, 2015: Participation at CPhI Worldwide in Madrid in October 2015; http://www.cphi.com
September 2, 2015: actrevo established new offices in Hamburg. Our new address is Neuer Wall 54, 20354 Hamburg, Germany.